Identifying the JAK2V617F mutation has improved understanding of what causes overproduction of red blood cells, platelets, and neutrophils in polycythemia vera.
In an analysis of 1,034 fit adults aged 70 years and younger, age and genetic features were identified as the factors most associated with AML outcomes.